Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-22

Clinical Trial Update: Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2 [NA]

View source ↗

Summary

Clinical trial update for the GORE TBE Device evaluating lesions of the aortic arch and descending thoracic aorta; the study remains active but not recruiting, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GORE TBE Device

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Aortic Aneurysm, Thoracic, Aorta; Lesion | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-11-22